Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | RO7567132 |
| Synonyms | |
| Therapy Description |
RO7567132 is a bispecific antibody targeting LTBR and FAP, which potentially induces expression of adhesion molecules, immune cell infiltration, and inhibition of tumor growth (Cancer Res (2025) 85 (8_Supplement_2): ND08). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| RO7567132 | RO 7567132|RO-7567132 | RO7567132 is a bispecific antibody targeting LTBR and FAP, which potentially induces expression of adhesion molecules, immune cell infiltration, and inhibition of tumor growth (Cancer Res (2025) 85 (8_Supplement_2): ND08). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|